Objective: To investigate the functional properties of insulin receptors with a Thr!Ser 1200 -mutation that is associated with severe insulin resistance in humans. Design and methods: The effect of in situ insulin-stimulation on insulin receptor kinase activity was studied in Chinese hamster ovary cells with overexpressed human Ser 1200 -mutated, non-mutated, and ATP-binding site-mutated (Lys!Arg 1030 ) receptors using a microwell-based assay that only detects human (and not hamster) insulin receptors. Moreover, the fraction of anti-phosphotyrosine antibodybinding receptors following in situ stimulation was separated, and autophosphorylation and kinase activity resulting from in situ and/or in vitro activation evaluated in this fraction. Results: Although insulin-stimulated kinase activity of human-speci®c anti-insulin receptor antibodybinding receptors in cells with Ser 1200 -mutated insulin receptors represented only 3.3% of that reached in cells with non-mutated receptors, a clear insulin-induced increase in kinase activity was observed (3.4-fold; P < 0.05). This increase was associated with a 2.360.6% (P < 0.05) increase in anti-phosphotyrosine-binding receptors with a kinase activity representing 4368% of that found in activated non-mutated receptors. In vitro autophosphorylation and kinase activation proceeded much more slowly in Ser 1200 -mutated receptors (t : 100 min) compared with non-mutated receptors (t : 1 min) and were inhibitable by lower alkaline phosphatase concentrations (EC 50 : 3 U/ml and 70 U/ml respectively). No activation of insulin receptor kinase was observed with Arg 1030 -mutated receptors. Conclusions: Overexpressed Ser 1200 -mutated human insulin receptors possess insulin-stimulated kinase activity and can be activated in situ and in vitro. They are characterized by a markedly slower autophosphorylation reaction, which, in a phosphatase-containing environment, results in a small fraction of phosphorylated and activated receptors.
Introduction
The insulin receptor is a heterotetrameric, transmembrane tyrosine kinase which undergoes ligand-activated autophosphorylation of tyrosine residues on its own b-subunit. This phosphorylation of certain tyrosine residues in the tyrosine kinase domain of the receptor is necessary to allow full activation of the receptor tyrosine kinase activity towards other substrates and to allow normal signaling to downstream effectors (1). Deactivation of the insulin receptor kinase occurs via receptor dephosphorylation by cellular phosphotyrosine-phosphatases (2).
The Trp!Ser 1200 insulin receptor mutation is one of several mutations found in the receptor kinase region that is associated with severe insulin resistance (3±9).
In a previous study, the insulin-stimulated glucose transport and glycogen synthesis were lower in Chinese hamster ovary (CHO) cells with overexpressed Ser 1200mutated receptors compared with CHO cells with overexpressed non-mutated receptors, but were higher than in CHO cells without insulin receptor overexpression (10). Since this increase by Trp!Ser 1200 insulin-receptor overexpression was observed (although insulin-stimulated receptor kinase activity in partially puri®ed cell extracts was similar to that of extracts from cells without human insulin receptor overexpression (10)), the possibility of receptor kinase-independent insulin signaling was discussed. In the present study, a microwell-based assay speci®c for human, but not hamster, insulin receptors (11) was used to determine if insulin stimulation activates the mutated receptors in CHO cells with overexpressed Ser 1200 -mutated insulin receptors. We show that the kinase of the Ser 1200mutated insulin receptors can be insulin-dependently activated in situ and in vitro. Their autophosphorylation, however, is much slower than that of non-mutated insulin receptors and therefore only a few of the mutated receptors are tyrosine-phosphorylated and activated in the in situ environment.
Materials and methods

Materials
Porcine monocomponent insulin was purchased from Novo Biolabs (Bagsvaerd, Denmark), insulin-like growth factor-I (IGF-I) was from Bissendorf (Hannover, Germany), [g-32 P]ATP (5000 Ci/mmol) was from DuPont-NEN (Dreieich, Germany) and [ 125 I-Tyr-A 14 ]monoiodoinsulin and [3-125 I]iodotyrosyl-IGF-I were from Amersham (Braunschweig, Germany). BSA was from Boehringer Mannheim (Mannheim, Germany) and materials for SDS±PAGE were from Bio-Rad (Mu È nchen, Germany). Goat anti-mouse IgG was from Dianova (Hamburg, Germany), mouse hybridoma cells producing a monoclonal antibody directed against the a-subunit of the human insulin receptor (aIR) were from the American Type Culture Collection (Rockville, MD, USA) and a monoclonal antibody against phosphotyrosine (aPY) was from Upstate Biotechnology (New York, NY, USA). A synthetic polymer with a 4:1 ratio of glutamic acid residues to tyrosine residues (Glu4:Tyr1) and other reagents were from Sigma (Mu È nchen, Germany).
Cell lines
Transfected CHO cells that overexpressed non-mutated human insulin receptors (non-mutated huIRs), human insulin receptors with a Lys!Arg 1030 mutation at the ATP-binding site (Arg 1030 -huIRs) or a Thr!Ser 1200 mutation (Ser 1200 -huIR) were kindly provided by Moller et al. (10) . In addition, CHO cells that expressed only the hamster insulin receptors (haIRs) were studied. Cells were grown in Ham's F-12 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 mg/ml streptomycin and 800 mg/ml geneticin at 37 8C under an atmosphere of 95% air and 5% CO 2 in 140-mm dishes.
Incubation and solubilization of cells
Con¯uent cells were ®rst preincubated with incubation buffer (20 mmol/l N-2-hydroxyethylpiperazine-N H -2ethanesulfonic acid (HEPES), 130 mmol/l NaCl, 4.8 mmol/l KCl, 1.3 mmol/l KH 2 PO 4 , 1 g/l D-glucose, 1.3 mmol/l MgSO 4 , 1.2 mmol/l CaCl 2 , 2% BSA, pH 7.4) for 30 min (37 8C). This buffer was then replaced by fresh incubation buffer, with or without 87 nmol/l insulin, and the cells incubated for 30 min. The buffer was then quickly removed and the dishes containing the cells were frozen in liquid nitrogen. The thin ice layer that contained the cells was scraped off the dishes at À20 8C and homogenized with a motor-driven homogenizer Potter S (Braun, Melsungen, Germany) in a solution that contained 2% Triton X-100, 5 mmol/l phenylmethylsulfonyl¯uoride, 800 U/ml aprotinin (trypsin inhibitor), 8 mmol/l EDTA, 30 mmol/l benzamidine, 2.5 mg/ml pepstatin, 2.5 mg/ml leupeptin, 160 mmol/l NaF, 10 mmol/l sodium pyrophosphate, 0.2 mmol/l sodium vanadate, 2 mmol/l dichloroacetic acid, and 20 mmol/l HEPES, pH 7.4 (®nal concentrations). Samples were then centrifuged at 10 5 g and 4 8C to remove insoluble material and stored at À80 8C.
Immobilization of receptors and measurement of receptor kinase and binding activities
This was performed essentially as described previously (11). Brie¯y, 30 ml aliquots of solubilized cell samples were pipetted into microwells coated with aIRs. After 16 h at 4 8C, the wells were washed and phosphorylation reactions were initiated in the wells by the addition of a mixture that contained [g-32 P]ATP (100±200 Ci/ mmol) and Glu4:Tyr1 (2 mg/ml). The radioactivity incorporated into Glu4:Tyr1 was then measured (11). Binding of insulin and/or IGF-I to immobilized receptors was measured in the wells, also as described elsewhere (11). Brie¯y, [ 125 I-Tyr-A 14 ]monoiodoinsulin or [3-125 I]iodotyrosyl-IGF-I (0.2 nmol/l in each case) was added to the wells in the absence or presence of unlabeled insulin or IGF-I. After 16 h at 4 8C, the wells were washed and the amount of bound radioactive ligands determined (11).
Selection of insulin receptors that bound to aPY
This was done essentially as described previously (2). Brie¯y, cell extracts or receptors that had been partially puri®ed by wheat-germ agglutinin±agarose chromatography were pipetted into aPY-coated microwells. After 16 h at 4 8C, the wells were washed and receptors that had bound to aPY were detached by the addition of 30 ml buffer containing 100 mmol/l phenylphosphate for 8 h at 4 8C (2). Detached receptors were then transferred to aIR-coated microwells for measurement of kinase activity and/or binding activities.
In vitro autophosphorylation and kinase activity of insulin receptors
To study in vitro autophosphorylation and kinase activity of immobilized receptors, wells were incubated with 0.5 mmol/l 32 P labeled or unlabeled ATP, respectively, for 24 h in buffer (0.5% Triton X-100, 100 mmol/l NaCl, 2.5 mmol/l KCl, 1 mmol/l CaCl 2 , 20 mmol/l HEPES, 10% glycerol, and 0.5% BSA, pH 7.4). For the detection of insulin receptor autophosphorylation receptors that had bound to aIR-coated microwells were detached by twice adding a solution of 2% SDS for 30 min. Then 32 P incorporation into the insulin receptor b-subunit was measured by autoradiography. Insulin receptor kinase activity was measured as described above.
Results
Insulin activation of insulin receptor kinase
Insulin stimulation of cells with overexpressed nonmutated huIRs resulted in an 8.5-fold increase in kinase activity of the subsequently immuno-immobilized receptors ( Fig. 1A ). An insulin-stimulated increase in kinase activity was also observed in cells with overexpressed Ser 1200 -huIRs ( Fig. 1B) ; this effect, however, was much smaller than in cells with overexpressed nonmutated huIRs (0.01 6 0.001 compared with 0.3 6 0.04 fmol P/fmol binding activity/min respectively). To exclude the possibility that this effect on insulin receptor kinase activity could be simply explained by the binding of parental haIRs to aIRs, aIR-coated microwells were also incubated with extracts of insulin-stimulated or non-insulin-stimulated CHO cells without overexpressed huIRs or with Arg 1030 -huIRs. In these wells, no insulin-binding activity was detectable (data not shown), indicating that no haIRs bound to the antibody. Moreover, in wells incubated with extracts from Arg 1030 -huIR cells, a binding activity was measured which was similar to that found in wells that had been incubated with Ser 1200 -huIR cells (data not shown) but, in contrast to the Ser 1200 -huIR cells, there was no kinase activation ( Fig. 1B) . Taken together, these data indicate that the increase in kinase activity observed with the immobilized receptors from Ser 1200 -huIR cells was in fact due to activation of Ser 1200 -mutated holoreceptors or possibly hybrids formed with the haIR-(Ser 1200 -huIR/haIR) and the haIGF-I receptor (Ser 1200 -huIR/haIGF-I).
Number and kinase activity of in situ-activated receptors
To explore whether the small, but signi®cant, kinase activation of receptors from Ser 1200 -huIR cells that bound to microwells coated with aIRs was the result of a small number of receptors being activated or a low kinase activity reached by the individual receptors, tyrosinephosphorylated receptors from insulin-stimulated cells were selected by immobilization to aPY. Only < 2±3% of the overexpressed insulin receptors from Ser 1200 -huIR cells (compared with < 50% of the receptors from nonmutated-huIR cells) bound to aPY ( Fig. 2A ), but the kinase activity per binding activity of those receptors that bound to aPY represented almost 50% of the kinase activity per receptor of similarly treated non-mutated huIRs (Fig. 2B ). This demonstrates that the increase in insulin-stimulated kinase activity that was measured in Ser 1200 -huIR cells was derived from a small fraction of tyrosine-phosphorylated receptors with almost half of the insulin-stimulated kinase activity of non-mutated huIRs.
In vitro autophosphorylation and kinase activity of Ser 1200 -huIRs
To test whether the human receptors from Ser 1200 -huIR cells were able to autophosphorylate, receptors from non-stimulated Ser 1200 -huIR cells were immobilized to aIR-coated microwells and exposed to insulin and ATP. This resulted in an autophosphorylation of the receptors (Fig. 3A ) and was associated with increased kinase Insulin receptors were immobilized to aIR-coated microwells and insulin receptor kinase and binding activities were measured as described in the methods section. Kinase activities were normalized for insulin binding activities in the respective wells and therefore re¯ect kinase activities per receptor. Microwells coated with aIRs were also incubated with extracts from insulin-stimulated or non-insulinstimulated CHO cells that only expressed haIRs. In these wells, no insulin-binding activity was detectable (data not shown). Values are means 6 S.E.M.; n = 6. *P<0.005 compared with cells without insulin-stimulation (paired t-test).
activity towards insulin receptor substrate-1 (IRS-1) (Fig. 3B ). Investigations were then directed towards establishing how many of the Ser 1200 -huIRs could be activated in vitro and what the time course of this activation was. With non-mutated huIRs, a rapid increase in the number of aPY-binding receptors was observed with half-maximal and maximal effects at 1 and 5 min respectively (Fig. 3C ). An increase in the number of aPY-binding receptors was also observed in wheat-germ eluates from Ser 1200 -huIR cells, and since the aPY-binding receptors were detected after they bound to aIRs they represented receptors with at least one Ser 1200 -mutated insulin receptor half. The increase in the number of aPY-binding receptors from Ser 1200 -huIR cells was, however, markedly slower than that observed with receptors from non-mutated huIR cells and reached at least 12% of all aIR-binding overexpressed insulin receptors after 48 h (half-maximal effect at < 100 min, Fig. 3C ).
In vitro autophosphorylation of non-mutated and Ser 1200 -huIRs in the presence of alkaline phosphatase
In cells, phosphotyrosine-phosphatases that dephosphorylate phosphorylated insulin receptors are present. It is therefore likely that slow insulin-stimulated receptor autophosphorylation shifts the equilibrium to the dephosphorylated state and thereby leads to the presence of only a few activated receptors. To test this hypothesis in an in vitro model, autophosphorylation of non-mutated-and Ser 1200 -huIRs was performed in the presence of alkaline phosphatase (Fig. 4) . At 20 U/ml alkaline phosphatase, the Ser 1200 -huIR reached only < 20% of the kinase activity attained in the absence of alkaline phosphatase, whereas the non-mutated-huIR reached < 80%. This indicates that the slow autophosphorylation of the Ser 1200 -huIRs severely impairs their activation in a phosphotyrosine-phosphatasecontaining environment.
IGF-I/insulin receptor hybrids
It is likely that only one huIR half is suf®cient for the binding to aIRs. It was therefore possible that receptors from insulin-incubated Ser 1200 -huIR cells that bound to aPY were Ser 1200 -huIR/haIGF-I hybrids. In order to differentiate between receptors that contained either two Ser 1200 -mutated-or one Ser 1200 -mutated huIR and one haIGF-I receptor half, binding of insulin and IGF-I to aIR-coated microwells that had been incubated with the aPY-precipitable fraction of extracts from insulinstimulated Ser 1200 -huIR cells was measured. The data show that those receptors that were phosphorylated in Ser 1200 -huIR cells and bound to aIRs had typical binding curves for insulin receptors (Fig. 5 ). This indicates that the fraction of insulin receptors that were tyrosine-phosphorylated following in situ insulin stimulation did not contain a substantial number of Ser 1200 -huIR/haIGF-I hybrids.
Discussion
Our data show that insulin stimulation of Ser 1200 -huIR cells led to a small, but signi®cant, kinase activation of receptors that bound to aIRs. No increase in insulinstimulated receptor kinase activity was observed in Arg 1030 -huIR cells or in haIR cells. This demonstrates that receptors with the Ser 1200 -mutation were insulindependently activated in the cells. The insulin-stimulated aPY and subsequently to aIRs. Cells with overexpressed non-mutated-, Ser 1200 -or Arg 1030 -huIRs were stimulated with 87 nmol/l insulin for 30 min at 37 8C, solubilized and added either directly to aIR-coated wells or previously to wells that were coated with aPY. After immobilization of tyrosine-phosphorylated proteins to the aPYcoated wells, wells were washed and bound proteins were detached with phenylphosphate and then immobilized to aIR-coated wells, as described in the methods section. Subsequently, kinase-and binding activities were measured. increase in kinase activity of the Ser 1200 -huIR cells might well explain the increased insulin effect on 2-deoxyglucose uptake and glucose incorporation into glycogen in these cells compared with cells without overexpression of human insulin receptors or expression of the Arg 1030mutated insulin receptor (10). In fat cells, the halfmaximal stimulation of glucose uptake occurred at an insulin concentration at which only 4% of the maximal kinase activity was reached (12), and in cells with overexpressed insulin receptors an even smaller percentage of the maximal insulin-stimulated kinase activity might be suf®cient to produce biological effects. Taken together, our data demonstrate that the Ser 1200 -huIRs that were overexpressed in CHO cells had insulinstimulated kinase activity and do not support the hypothesis that the receptor kinase might not be required for the stimulation of biological insulin effects (10). The slight increase in the overall human insulin receptor kinase activity measured in insulin-stimulated Ser 1200 -huIR cells was not the result of a slight increase in the kinase activity of all or most cellular insulin receptors, but rather resulted from the activation of only approximately 2±3% of the cellular receptors that exhibited < 50% of the kinase per binding activity of that reached in insulin-stimulated non-mutated huIRs. These results led us to further explore the functional properties of aIR-binding receptors from Ser 1200 -huIR cells that were tyrosine-phosphorylated by insulin incubation of the cells. It was possible that these receptors were unable to autophosphorylate and that their kinase activation resulted from intermolecular Figure 4 In vitro autophosphorylation of Ser 1200 -and non-mutated huIRs in the presence of alkaline phosphatase. Receptors from cells that overexpressed non-mutated (A) or Ser 1200 -huIRs (X) were immobilized to microwells coated with aIRs. Immunoimmobilized receptors were then incubated for 24 h with 0.5 mmol/l ATP in the presence of the indicated concentrations of alkaline phosphatase. Wells were washed and insulin receptor kinase activity measured as described. Receptor kinase activity is shown in percent receptor kinase activity after in vitro incubation of the wells in the absence of alkaline phosphatase. Values are means of two experiments. Figure 3 In vitro autophosphorylation and kinase activation of receptors that bound to aIR. Insulin receptors from cells that overexpressed the respective insulin receptors were immobilized to microwells coated with aIRs and subsequently incubated with 0.5 mmol/l 32 P labeled (A) or unlabeled (B) ATP, respectively, for 24 h, as described in the methods section. For the detection of insulin-receptor autophosphorylation (A), 32 P was collected by twice adding a solution of 2% SDS for 30 min. For the measurement of insulin-receptor kinase activity (B), 32 P was collected from the supernatant of in vitro-incubated wells after the addition of a mixture that contained [ 32 P]ATP and recombinant insulin-receptor substrate-1 (IRS-1). Proteins were then separated by SDS±PAGE and 32 P-incorporation into the receptor b-subunit (A, 95 kDa) or IRS-1 (B, 170 kDa) was measured by autoradiography. Counts per minute (c.p.m.), as obtained from Fig. 3A and B respectively were as follows: (1) were partially puri®ed by wheat-germ agglutinin±agarose chromatography, incubated with 0.5 mmol/l ATP for the indicated times and the reaction stopped by the addition of kinase-and phosphataseinhibitors (C). The receptors were then either directly immobilized to aIR-coated wells or the aPY-binding fraction was ®rst selected as described in the methods section. The amount of tyrosinephosphorylated insulin receptors that bound to aPY and aIRs is shown as a percentage of the total amount of receptors that bound directly to aIRs. Values are means of three experiments. phosphorylation by other cellular receptors, as previously described with cells expressing both wild-type and Ile 1153 -mutated human insulin receptors (13). The Ser 1200 -receptors were, however, insulin-dependently phosphorylated in vitro following their immunoimmobilization to microwells coated with aIRs and this also resulted in their activation for the phosphorylation of IRS-1. These results demonstrate that these receptors were able to autophosphorylate and indicate that their activation in the cells was at least not dependent on phosphorylation by other receptors.
The rate of in vitro autophosphorylation of the Ser 1200 -huIR was much slower compared with the non-mutated huIR. After 24 h of in vitro incubation with insulin and ATP, < 12% bound to aPY indicating that at least this percentage of the aIR-binding receptors from Ser 1200 -huIR cells were able to autophosphorylate. Conversely, only < 2±3% of the aIR-binding insulin receptors were activated by maximal insulin stimulation of the Ser 1200 -huIR cells. This may be explained by the slow autophosphorylation of the mutated receptors in the presence of phosphotyrosine-phosphatases in the cellular environment. Phosphotyrosine-phosphatases strongly counterbalance insulin receptor activation (2) and thus a slow autophosphorylation results in a shift of the equilibrium between receptor autophosphorylation and dephosphorylation. Accordingly, we have demonstrated in vitro that in the presence of 20 U/ml alkaline phosphatase Ser 1200 -huIR reaches only < 20% of the kinase activity attained in the absence of alkaline phosphatase, whereas non-mutated huIR reaches < 80%.
Receptor halves from human insulin receptors that are expressed in rodent cells can dimerize with endogenous receptor halves (14±16). It is therefore possible that in situ-activated receptors that bound to aIRs were not Ser 1200 -mutated holoreceptors but represented a subfraction of the aIR-binding receptors, e.g. hybrids that contained one human insulin and one hamster insulin or IGF-I receptor half. We found that at least 12% of the overexpressed receptors from Ser 1200 -huIR cells were able to autophosphorylate, and therefore, with these estimates, the possibility remains that the receptors from insulinstimulated Ser 1200 -huIR cells that were able to autophosphorylate were Ser 1200 -huIR/haIR hybrids.
In any case, even if they represented such hybrids, the Ser 1200 -huIR/haIR receptors would presumably be functionally similar to the Ser 1200 -huIR/non-mutated huIR receptor that probably represents the most abundant insulin receptor structure in the heterozygous patient with this mutation (10). Most of the naturally occurring point mutations in the regulatory domain of the insulin receptor kinase (1002±1257) were reported to result in a complete loss of the insulin-stimulated receptor activity (3, 7, 17) . There are also reports, consistent with our results, that describe mutated receptors that only partially impair the in vitro (18) or in situ (19) autophosphorylation. The functional characteristics of these mutations, however, have not been evaluated to the same extent as in the present study. In particular, a mutation with a < 100fold slower autophosphorylation, but only 50% decreased kinase activity if autophosphorylated, to our knowledge has not been described. It is, however, possible that other insulin receptor mutations with 
